Ozanimod shows efficacy in two-year study extension
Ozanimod shows efficacy in two-year study extension
Results from the extension period of a Phase II trial, assessing Ozanimod as a potential treatment for relapsing-remitting multiple sclerosis, showed that the drug can effectively and safely improve clinical measures of RRMS after two years of treatment...Read more - http://www.ms-uk.org/ozanimod-shows-eff ... ion-260916
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1386 Views
-
Last post by frodo
-
- 0 Replies
- 11032 Views
-
Last post by NHE
-
- 0 Replies
- 1028 Views
-
Last post by frodo
-
- 0 Replies
- 1428 Views
-
Last post by NHE
-
- 0 Replies
- 2281 Views
-
Last post by DIM
-
- 0 Replies
- 2017 Views
-
Last post by DIM
-
- 0 Replies
- 1652 Views
-
Last post by frodo
-
- 0 Replies
- 1986 Views
-
Last post by Tif